buserelin has been researched along with fluorouracil in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falkson, CI; Falkson, G; Falkson, HC | 2 |
| Falkson, G; Falkson, HC | 1 |
| Jonat, W | 1 |
| Cheson, BD | 1 |
2 trial(s) available for buserelin and fluorouracil
| Article | Year |
|---|---|
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Delayed-Action Preparations; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Ovary | 1992 |
Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Doxorubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Methotrexate; Middle Aged; Ovary; Time Factors | 1991 |
3 other study(ies) available for buserelin and fluorouracil
| Article | Year |
|---|---|
CAF and nasal buserelin in the treatment of premenopausal women with metastatic breast cancer.
Topics: Administration, Intranasal; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged | 1989 |
LHRH analogues in early breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Middle Aged | 1989 |
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen | 1989 |